Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 9, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc.
| 2.36K |
$11.52 | -$50,538.24 | +3.10% | 78.63K | +1 |
Sep 5 - Sep 9
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| 20.24K |
$8.71 | -$41,495.32 | +36.11% | 76.27K | +1 |
Jan 31 - Feb 1
| ||||||
Travere Therapeutics, Inc.
| -2.06K |
$8.96 | -$18,475.52 | -3.55% | 56.03K | +1 |
Jan 23
| ||||||
Travere Therapeutics, Inc.
| 1.49K |
$14.71 | -$26,698.65 | +2.62% | 58.1K | +1 |
Aug 31 - Sep 5
| ||||||
Travere Therapeutics, Inc.
| -825.00 |
$16.59 | -$13,686.75 | -1.44% | 56.61K | +1 |
May 10
| ||||||
Travere Therapeutics, Inc.
| 17.66K |
$22.25 | -$57,627.50 | +44.40% | 57.44K | +1 |
Jan 31 - Feb 1
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| -2.06K |
$21.50 | -$44,333.00 | -4.93% | 39.78K | +1 |
Jan 24
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| -1.95K |
$21.51 | -$41,943.45 | -4.45% | 41.84K | +1 |
May 10 - May 12
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| 8.49K |
$27.40 | -$36,990.00 | +24.05% | 43.79K | +1 |
Jan 31
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| -2.25K |
$24.98 | -$56,205.00 | -5.99% | 35.3K | +1 |
Jan 24
|
Scheduled
| |||||
Travere Therapeutics, Inc.
|
0
|
$27.40 | -$137,000.00 |
—
| 37.55K | +1 |
Jan 10 - Jan 11
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| 3.09K |
$17.12 | -$24,086.01 | +8.98% | 37.55K | +1 |
Aug 13 - Aug 17
| ||||||
Travere Therapeutics, Inc.
| -3.25K |
$19.30 | -$62,725.00 | -8.62% | 34.45K | +1 |
May 11 - May 12
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| -4.50K |
$31.50 | -$141,727.50 | -10.66% | 37.7K | +1 |
Feb 5 - Feb 8
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| 4.5K |
—
|
—
| +11.93% | 42.2K | +1 |
Feb 3
| ||||||
Travere Therapeutics, Inc.
| -3.17K |
$28.91 | -$91,789.25 | -7.77% | 37.7K | +1 |
Feb 3
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| 1.82K |
$30.75 | -$97,631.25 | +4.67% | 40.88K | +1 |
Jan 31 - Feb 2
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| 15K |
—
|
—
| +62.36% | 39.05K | +1 |
Jan 21
| ||||||
Travere Therapeutics, Inc.
| -1.38K |
$26.83 | -$36,918.08 | -5.41% | 24.05K | +1 |
Jan 5 - Jan 6
|
Scheduled
| |||||
Travere Therapeutics, Inc.
| -2.50K |
$23.98 | -$59,950.00 | -8.95% | 25.43K | +1 |
Nov 16
|
Scheduled
| |||||
Retrophin, Inc.
| 2.5K |
$23.62 | -$59,045.50 | +9.83% | 27.93K | +1 |
Nov 11 - Nov 13
|
Scheduled
| |||||
Retrophin, Inc.
| -1.50K |
$18.48 | -$27,720.00 | -5.57% | 25.43K | +1 |
Sep 23
|
Scheduled
| |||||
Retrophin, Inc.
| 1.5K |
$18.59 | -$27,885.00 | +5.90% | 26.93K | +1 |
Sep 18 - Sep 22
|
Scheduled
| |||||
Retrophin, Inc.
| -1.58K |
$16.37 | -$25,808.48 | -5.84% | 25.43K | +1 |
May 11 - May 12
|
Scheduled
| |||||
Retrophin, Inc.
| -3.50K |
$15.02 | -$52,570.00 | -11.47% | 27.01K | +1 |
Mar 10
|
Scheduled
| |||||
Retrophin, Inc.
| 3.5K |
—
|
—
| +12.96% | 30.51K | +1 |
Mar 5
| ||||||
Retrophin, Inc.
| 9K |
—
|
—
| +49.98% | 27.01K | +1 |
Jan 31
| ||||||
Retrophin, Inc.
| -1.50K |
$14.54 | -$21,810.00 | -7.69% | 18.01K | +1 |
Jan 7 - Jan 8
|
Scheduled
| |||||
Retrophin, Inc.
| -1.05K |
$17.73 | -$18,616.50 | -5.11% | 19.51K | +1 |
May 14 - May 15
|
Scheduled
| |||||
Retrophin, Inc.
| 6K |
—
|
—
| +41.21% | 20.56K | +1 |
May 9
| ||||||
Retrophin, Inc.
| -1.77K |
$21.44 | -$37,927.30 | -10.83% | 14.56K | +1 |
Feb 11 - Feb 12
|
Scheduled
| |||||
Retrophin, Inc.
| -1.50K |
$23.96 | -$35,932.50 | -8.41% | 16.33K | +1 |
Jan 8 - Jan 9
|
Scheduled
| |||||
Retrophin, Inc.
| -5.00K |
$24.03 | -$120,145.93 | -21.90% | 17.83K | +1 |
Nov 14 - Nov 15
|
Scheduled
| |||||
Retrophin, Inc.
| 5K |
—
|
—
| +28.05% | 22.83K | +1 |
Nov 9
| ||||||
Retrophin, Inc.
| 7K |
—
|
—
| +64.65% | 17.83K | +1 |
May 10
| ||||||
Retrophin, Inc.
| 1.77K |
—
|
—
| +19.53% | 10.83K | +1 |
Feb 8
| ||||||
Retrophin, Inc.
| -942.00 |
$24.04 | -$22,645.68 | -9.42% | 9.06K | +1 |
Jan 5
| ||||||
Retrophin, Inc.
| 10K |
—
|
—
|
∞
| 10K | +1 |
Jan 4
| ||||||
Retrophin, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Celladon Corp
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 1
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.